Chindex (CHDX) Receives Key China Approvals
More News related to CHDX
- Chindex International, Inc. Announces Opening of the Guangzhou UFH Center
- Halter USX China Index Announces Third Quarter 2008 Results and Adds New Constituents
- Chindex International (CHDX) Announces Second daVinci Sale
- Chindex International, Inc. Announces Second daVinci Sale
- Chindex Int'l (CHDX) Medical Products Unit Wins Major Supply Contract
More News related to CLZR
- Wall Street Media Presents Exclusive Conference Videos
- Texas Jury Rules Against Candela in Its Patent Infringement Lawsuit Against Palomar Medical Technologies
- Candela to Present at Maxim Growth Conference October 7, 2008
- Candela (CLZR) Misses Q2 EPS by 3c; Guides
- Candela Reports Fourth Quarter and Fiscal Year 2008 Results
More News related to ISRG
- Intuitive Surgical Deploys FusionOps Procurement and Supplier Collaboration Solution for Worldwide Manufacturing
- Chindex International (CHDX) Announces Second daVinci Sale
- REMINDER: OR-Live.com Presents: Surgical Tutorial on Complex da Vinci(R) Hysterectomy -- Strategies for Managing Endometriosis, Prior Pelvic Surgery and Large Uteri
- REMINDER: ORLive Presents: Robotic-Assisted Minimally Invasive Hysterectomy
- Analyst Reports for Take-Two Interactive Software Inc., TurboChef Technologies Inc., Intuitive Surgical Inc. and Clean Harbors Inc.
More News related to FDA
- Angiotech (ANPI) Reports Boston Scientific (BSX) Receives FDA Approval to Market its second-generation TAXUS Liberte
- AstraZeneca (AZN) Receives FDA Approval for Once-Daily SEROQUEL XR(R)
- Medicis (MRX) Receives FDA Approval of PMA Supplement for RESTYLANE(R)
- Biogen Idec (BIIB) Said Baminercept Trial Failed To Meet Primary Endpoint
Chindex International, Inc. (Nasdaq: CHDX) received long-awaited approval from the State Food and Drug Administration of the People's Republic of China to introduce new products, including the daVinci S Surgical System manufactured by Intuitive Surgical (Nasdaq: ISRG) and the AlexLaser manufactured by Candela Corporation (Nasdaq: CLZR).
The receipt of the SFDA Certificates will allow Chindex to begin the sales process and launch official marketing programs for these products, creating a wealth of new market opportunities for the Company.
Related Categories
Corporate NewsFDA
Stocks Mentioned
+1.19Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
